| 2007 |
AMBRA1 is a positive regulator of BECLIN1-dependent autophagy; it bears a WD40 domain and interacts with BECLIN1 to promote autophagosome formation. Loss of AMBRA1 function in mouse embryos impairs autophagy, causes accumulation of ubiquitinated proteins, and leads to severe neural tube defects with unbalanced cell proliferation and excessive apoptosis. |
RNA interference in vitro, overexpression assays, mouse genetic knockout model with phenotypic analysis |
Nature |
High |
17589504
|
| 2010 |
Under basal conditions, the BECLIN1-VPS34 complex is tethered to the dynein motor complex via AMBRA1's direct interaction with dynein light chains DLC1/2. Upon autophagy induction, ULK1 phosphorylates AMBRA1, releasing it from dynein; the complex then relocalizes to the endoplasmic reticulum, enabling autophagosome nucleation. |
Co-immunoprecipitation, live-cell imaging, ULK1 kinase assays, DLC1 knockdown, AMBRA1 DLC1-binding site mutagenesis |
The Journal of cell biology |
High |
20921139 21079415
|
| 2011 |
Mitochondrial BCL-2 binds AMBRA1 and inhibits AMBRA1-induced autophagy. AMBRA1 preferentially binds the mitochondrial pool of BCL-2; upon autophagy induction this interaction is disrupted and AMBRA1 is recruited to BECLIN1. AMBRA1 can compete with both mitochondrial and ER-resident BCL-2 for BECLIN1 binding. |
Co-immunoprecipitation, subcellular fractionation, overexpression and knockdown assays |
The EMBO journal |
Medium |
21358617
|
| 2011 |
Parkin interacts with AMBRA1 (identified by tandem affinity purification/mass spectrometry from HEK293 cells and validated by endogenous Co-IP). Upon prolonged mitochondrial depolarization, the Parkin–AMBRA1 interaction increases; AMBRA1 is recruited to perinuclear clusters of depolarized mitochondria in a Parkin-dependent manner and activates class III PI3K locally, promoting mitophagic clearance. |
Tandem affinity purification, mass spectrometry, endogenous Co-immunoprecipitation from HEK293, SH-SY5Y cells and adult mouse brain, siRNA knockdown, fluorescence microscopy |
The Journal of neuroscience |
High |
21753002 21921694
|
| 2012 |
During apoptosis, AMBRA1 is proteolytically degraded by the combined action of caspases (cleaving at D482) and calpains (mediating complete degradation), dismantling autophagic activity. AMBRA1 levels are critical for the rate of apoptosis: RNAi-mediated knockdown sensitizes cells to apoptotic stimuli, while a caspase-non-cleavable AMBRA1 mutant prolongs autophagy and counteracts cell death. |
In vitro cleavage assays, caspase/calpain inhibitor treatment, site-directed mutagenesis (D482 site), RNA interference, cell death assays |
Cell death and differentiation |
High |
22441670
|
| 2013 |
Under non-autophagic conditions, mTOR phosphorylates and inhibits AMBRA1. Upon autophagy induction, AMBRA1 is dephosphorylated and interacts with the E3 ligase TRAF6, supporting K63-linked ubiquitylation of ULK1, thereby stabilizing ULK1, promoting its self-association and function. ULK1 in turn activates AMBRA1 by phosphorylation, forming a positive feedback loop. |
Co-immunoprecipitation, ubiquitylation assays (K63-linkage specific), phosphorylation mapping, autophagy flux assays, mTOR inhibition experiments |
Nature cell biology |
High |
23524951
|
| 2014 |
AMBRA1 regulates cell proliferation by facilitating dephosphorylation and degradation of c-Myc: AMBRA1 directly interacts with the phosphatase PP2A and enhances PP2A activity on c-Myc when mTOR is inhibited, reducing the cell division rate. AMBRA1-defective systems show deregulated c-Myc and increased tumorigenesis, establishing AMBRA1 as a haploinsufficient tumor suppressor. |
Co-immunoprecipitation (AMBRA1–PP2A interaction), PP2A phosphatase activity assay on c-Myc substrate, cell proliferation assays, mouse tumor models |
Nature cell biology |
High |
25438055
|
| 2014 |
Cullin-4 E3 ubiquitin ligase binds AMBRA1 under basal conditions, limiting AMBRA1 protein abundance. Autophagy stimuli cause ULK1-dependent Cullin-4 release, stabilizing AMBRA1. Re-establishment of Cullin-4/AMBRA1 interaction later triggers AMBRA1 degradation, terminating autophagy. Upon Cullin-4 dissociation, AMBRA1 binds and inhibits Cullin-5, promoting DEPTOR accumulation and mTOR inhibition as a positive feedback loop. |
Co-immunoprecipitation, protein stability assays, autophagy flux measurement, ULK1 kinase-dependent dissociation assays |
Developmental cell |
High |
25499913
|
| 2014 |
RNF2 associates with AMBRA1 as a K48-linked ubiquitin E3 ligase, ubiquitinating AMBRA1 at lysine 45 and targeting it for proteasomal degradation. WASH protein recruits RNF2 to AMBRA1; WASH deficiency impairs RNF2–AMBRA1 association and AMBRA1 degradation, thereby upregulating autophagy. |
Co-immunoprecipitation, in vitro ubiquitination assay with ubiquitin linkage mapping (K48), site-directed mutagenesis (K45), RNAi knockdown of RNF2 and WASH |
Cell research |
High |
24980959
|
| 2016 |
The C-terminal fragment of AMBRA1 generated by caspase cleavage contains a BH3-like domain that directly binds and inhibits the antiapoptotic factor BCL-2, acting in a proapoptotic positive feedback loop during mitochondrial apoptosis. |
Co-immunoprecipitation of AMBRA1-CT with BCL-2, BH3 domain mutagenesis, apoptosis assays |
Autophagy |
Medium |
27123694
|
| 2017 |
AMBRA1 acts as a 'spatial rheostat' controlling Src/FAK signaling: it binds both FAK and Src in cancer cells, recruits active phospho-Src away from focal adhesions into autophagic structures, and regulates cancer cell invasion. When FAK is present, AMBRA1 is recruited to focal adhesions, promoting FAK-dependent direction-sensing. Dynactin-1 and IFITM3 were identified as AMBRA1 binding partners mediating this trafficking function. |
Interaction proteomics (affinity purification-MS), Co-immunoprecipitation, live-cell imaging, AMBRA1 knockdown/rescue in squamous cell carcinoma cells, invasion assays |
eLife |
Medium |
28362576
|
| 2018 |
AMBRA1 controls regulatory T cell (Treg) differentiation by interacting with PP2A phosphatase, promoting FOXO3 stability, which triggers FOXP3 transcription. AMBRA1 regulates Treg induction in vivo in tumor and multiple sclerosis mouse models. |
Co-immunoprecipitation (AMBRA1–PP2A), FOXO3 stability assays, AMBRA1 knockdown in T cells, in vivo mouse models |
Developmental cell |
Medium |
30513302
|
| 2018 |
HUWE1 E3 ubiquitin ligase is a key inducer of AMBRA1-mediated, PINK1/PARKIN-independent mitophagy. HUWE1 activity enables IKKα to phosphorylate AMBRA1 at serine 1014, inducing structural changes in AMBRA1 that promote its interaction with LC3/GABARAP proteins and activate mitophagy. |
Co-immunoprecipitation, in vitro kinase assay (IKKα on AMBRA1-S1014), AMBRA1 phospho-mutant analysis, LC3 interaction assays, mitophagy flux assays |
Nature communications |
High |
30217973
|
| 2018 |
HPV-E7 protein interacts with AMBRA1 and competes with its binding to BECLIN1, triggering calpain-dependent AMBRA1 degradation, thereby reducing autophagy activity in HPV-positive oropharyngeal squamous cell carcinoma cells. |
Co-immunoprecipitation, calpain inhibitor assays, competition binding experiments, autophagy flux assays |
Autophagy |
Medium |
33172332
|
| 2019 |
MCL-1 inhibits AMBRA1-mediated mitophagy by blocking recruitment of HUWE1 E3 ligase to mitochondria. During AMBRA1-mediated mitophagy, GSK-3β phosphorylates MCL1 at S159, leading to HUWE1-dependent MCL1 degradation. GSK-3β inhibition sustains MCL1 levels and delays mitophagy. |
Co-immunoprecipitation, GSK-3β kinase assay, MCL1 phospho-mutant (S159A), HUWE1 knockdown, mitophagy flux assays |
Cell death and differentiation |
Medium |
31434979
|
| 2019 |
TRIM32 E3 ubiquitin ligase is conveyed to ULK1 by AMBRA1 in muscle cells, stimulating ULK1 kinase activity through unanchored K63-linked polyubiquitin chains to induce autophagy upon atrophy. Limb-girdle muscular dystrophy 2H mutations in TRIM32 disrupt its ability to bind ULK1 and to induce autophagy. |
Co-immunoprecipitation, ULK1 kinase activity assay, ubiquitin linkage analysis, TRIM32 disease-mutation functional assays in muscle cells |
Autophagy |
Medium |
31234693
|
| 2020 |
AMBRA1 interacts with ERLIN1 at mitochondria-associated membrane (MAM) raft-like microdomains, and this interaction is required for autophagosome formation upon nutrient starvation. The interaction depends on ganglioside GD3 and MFN2 integrity; knockdown of ERLIN1, ST8SIA1, or MFN2 impairs AMBRA1–ERLIN1 interaction and autophagy. |
Co-immunoprecipitation, FRET microscopy, subcellular fractionation to MAMs, ERLIN1/GD3-synthase/MFN2 knockdown, autophagy flux assays |
Autophagy |
Medium |
33034545
|
| 2021 |
AMBRA1 serves as the substrate receptor for the CUL4-RING E3 ubiquitin ligase complex (CRL4AMBRA1/CRL4DCAF3) that ubiquitylates all three D-type cyclins (D1, D2, D3) for proteasomal degradation. Loss of AMBRA1 leads to cyclin D accumulation, RB hyperphosphorylation, and hyperproliferation. Cancer hotspot mutations in D-type cyclins abrogate their binding to AMBRA1 and stabilize them. |
Biochemical reconstitution of ubiquitylation, genome-wide CRISPR-Cas9 screen, Co-immunoprecipitation, mouse genetic models, in vitro ubiquitination assay, cancer mutation binding assays |
Nature |
High |
33854232 33854235 33854239
|
| 2021 |
AMBRA1 regulates the G1-to-S phase transition and prevents replication stress by mediating proteasomal degradation of D-type cyclins and by controlling MYC/MYCN-mediated transcription of cyclin genes. AMBRA1-deficient cells show replication stress and CHK1 kinase dependency as a synthetic lethal vulnerability. |
Cyclin D stability assays, cell cycle analysis, DNA fiber assays (replication stress), CHK1 inhibitor synthetic lethality screen, in vivo neural stem cell and mouse models |
Nature |
High |
33854232
|
| 2021 |
Upon mitochondrial depolarization, AMBRA1 is recruited to the outer mitochondrial membrane and interacts with PINK1 and ATAD3A (a transmembrane protein mediating PINK1 import and degradation). AMBRA1 deficiency reduces PINK1 stability by enhancing its degradation via the mitochondrial protease LONP1, decreasing PINK1-mediated ubiquitin phosphorylation and PARKIN recruitment. ATAD3A silencing rescues defective PINK1 accumulation in AMBRA1-deficient cells. |
Co-immunoprecipitation (AMBRA1–PINK1, AMBRA1–ATAD3A), AMBRA1 knockdown/ATAD3A knockdown epistasis, LONP1-dependent PINK1 degradation assays, mitophagy flux assays |
Autophagy |
High |
34798798
|
| 2021 |
AMBRA1 (as the CRL4 substrate receptor) targets Elongin C (ELOC), the shared adapter of CRL5 ubiquitin ligase complexes, for polyubiquitination and degradation, thereby attenuating CRL5SOCS3 and CRL5VIF ligase activity. This cross-regulation modulates IL-6/STAT3 signaling and HIV-1 infectivity. |
Proteomics (affinity purification-MS), in vitro ubiquitination assay, Co-immunoprecipitation, CRL5 assembly assays, IL-6/STAT3 reporter assays, HIV infectivity assays |
The EMBO journal |
High |
30166453
|
| 2021 |
AMBRA1 promotes TGFβ signaling as the substrate receptor of the CRL4 ubiquitin ligase complex, mediating nonproteolytic polyubiquitylation of Smad4 to enhance its transcriptional activity, thereby promoting TGFβ-induced EMT, migration, and invasion of breast cancer cells and metastasis in mouse models. |
Co-immunoprecipitation, in vitro ubiquitination assay, reporter gene assays, AMBRA1 knockdown/overexpression, mouse metastasis models |
Cancer research |
Medium |
34362797
|
| 2021 |
AMBRA1 negatively regulates ALDH1B1 (a cancer stem cell marker) by mediating its K27- and K33-linked non-canonical ubiquitination in cooperation with TRAF6. Ubiquitination sites K506, K511, and K515 are important; ubiquitination-defective ALDH1B1 shows increased self-association, suggesting ubiquitination suppresses ALDH1B1 oligomerization. |
Co-immunoprecipitation, in vitro ubiquitination assay with ubiquitin linkage mapping (K27, K33), site-directed mutagenesis, self-association assays |
International journal of molecular sciences |
Medium |
34769507
|
| 2022 |
Ambra1 deficiency in skeletal muscle (muscle-specific knockout) impairs mitophagic flux without affecting bulk autophagy, causing accumulation of TOMM20, swollen mitochondria, reduced mitochondrial membrane potential, decreased complex I activity, reduced recruitment of DRP1 and Parkin to mitochondria, and lysosomal accumulation. Overexpression of mitochondria-targeted Ambra1 in wild-type muscle is sufficient to enhance mitochondria clearance. |
Muscle-specific conditional Ambra1 knockout mice (Ambra1fl/fl:Mlc1f-Cre), in vivo Ambra1 overexpression, mitochondrial fractionation, electron microscopy, respiratory complex activity assay, mitophagy flux assays |
Journal of cachexia, sarcopenia and muscle |
High |
35593053
|
| 2023 |
AMBRA1 is phosphorylated during mitosis by CDK1 and PLK1 on multiple sites. This phosphorylation is required for proper mitotic spindle orientation, mediated through NUMA1. AMBRA1 localization and/or dynamics of NUMA1 are strictly dependent on AMBRA1 presence, phosphorylation, and binding ability. |
Phosphorylation mapping during mitotic arrest, CDK1/PLK1 kinase assays, AMBRA1 phospho-mutant analysis, NUMA1 localization by imaging, spindle orientation assays |
Cellular and molecular life sciences |
Medium |
37584777
|
| 2023 |
Cryo-EM structure of AMBRA1 in complex with DDB1 resolved at 3.08 Å. The N-terminal helix-loop-helix motif and WD40 domain of AMBRA1 associate with the double-propeller fold of DDB1, creating a scaffold for substrate recruitment. DDB1-binding-defective AMBRA1 mutants prevent Cyclin D1 ubiquitination in vitro and increase cell cycle progression. |
Cryo-EM structure determination, HDX-MS, in vitro ubiquitination assay, DDB1-binding mutagenesis, cell cycle assays |
Nature communications |
High |
37993427
|
| 2022 |
AMBRA1 interacts with MAVS (mitochondrial antiviral signaling protein) at mitochondria and stabilizes MAVS by preventing its dsRNA-induced proteasomal degradation, thereby promoting dsRNA- and virus-induced apoptosis through a caspase-8-dependent pathway. |
Co-immunoprecipitation (AMBRA1–MAVS), AMBRA1 gene editing (knockout), proteasome inhibitor assays, apoptosis assays, Semliki Forest virus infection model |
Journal of cell science |
Medium |
34859815
|
| 2024 |
BAG2, an effector of the ULK1 complex, regulates AMBRA1 subcellular localization. In nutrient-replete conditions, unphosphorylated BAG2 sequesters AMBRA1, attenuating autophagy. Upon starvation, ULK1 phosphorylates BAG2 at Ser31, which promotes AMBRA1 recruitment to the ER membrane and autophagy induction. |
Affinity purification-MS and proximity labeling-MS interactome of ULK1 complex subunits, Co-immunoprecipitation, BAG2 phospho-mutant (S31A), AMBRA1 localization imaging |
Cell reports |
Medium |
39207901
|
| 2024 |
AMBRA1 promotes intestinal NF-κB-driven inflammation in an autophagy-independent manner by antagonizing the PP4R1/PP4c phosphatase complex: the N-terminal F1 domain of AMBRA1 competitively binds PP4R1, disrupting PP4R1/PP4c interaction with IKK and preventing IKK dephosphorylation. Upon TNF-α stimulation, IKKα phosphorylates AMBRA1 at S1043, impairing its CUL4A-mediated K48-linked ubiquitination and stabilizing AMBRA1. |
Co-immunoprecipitation (AMBRA1–PP4R1, AMBRA1–PP4c, AMBRA1–IKK), AMBRA1 domain deletion/mutagenesis (F1 domain, S1043), IKKα kinase assay, CUL4A ubiquitination assay, AMBRA1 conditional knockout mice |
Cell death and differentiation |
High |
38424148
|
| 2025 |
In intestinal epithelial cells, AMBRA1 acts as a pro-oxidative factor by competitively binding NRF2 through its N-terminal F1 domain, antagonizing DUB3-mediated NRF2 deubiquitination and promoting NRF2 degradation. Under oxidative stress (H2O2), USP7 interaction with AMBRA1 is enhanced, leading to USP7-mediated deubiquitination of AMBRA1 at K83 and K86, stabilizing AMBRA1. |
Co-immunoprecipitation (AMBRA1–NRF2, AMBRA1–DUB3, AMBRA1–USP7), domain mutagenesis (F1 domain, K83/K86 sites), in vitro deubiquitination assay, AMBRA1 conditional knockout mice, IBD patient tissue analysis |
Advanced science |
Medium |
39887666
|
| 2017 |
AMBRA1 binds α-synuclein phosphorylated at serine 129 with ~9-fold higher affinity than non-phosphorylated α-synuclein (in vitro and in vivo analyses). Silencing AMBRA1 function causes α-synuclein aggregates in the cytoplasm of mouse primary neurons, similar to the effect of the autophagy inhibitor Bafilomycin. |
Binding affinity assays (in vitro and in vivo), AMBRA1 knockdown in primary neurons, immunohistochemistry of human MSA brain samples |
Brain pathology |
Medium |
27875637
|
| 2021 |
AMBRA1 suppresses SOCS3 in medulloblastoma Group 3 stem cells, enabling STAT3 activation. AMBRA1 expression depends on c-MYC levels, and AMBRA1 knockdown reduces stem potential, growth, and migration of MBGroup3 cells. Combined anti-autophagy and anti-STAT3 treatment impacts MBGroup3 outcome. |
AMBRA1 knockdown/overexpression, SOCS3 expression assays, STAT3 activation assays, tumor sphere formation, migration assays |
Acta neuropathologica |
Medium |
34302498
|
| 2021 |
Loss of Ambra1 in melanoma promotes aggressiveness and metastasis by increasing cell motility/invasion, activating an EMT-like process, remodeling the extracellular matrix, and inducing hyperactivation of FAK1 signaling. FAK1 inhibition reduces cell invasion and melanoma growth in Ambra1-deficient cells. |
Ambra1-depleted Braf/Pten mouse melanoma model, invasion and migration assays, EMT marker analysis, FAK1 phosphorylation assays, FAK1 pharmacological inhibition |
Nature communications |
Medium |
33953176
|